the journal of Pharmacy Technology the journal of Pharmacy Technology
Abstracts of Back Issues
Home
Home
Back Issues
Author Information
PharmaCE
Acknowledgments
About the journal
Order Form
Customer Service
Advertising Information
Contact Information


NEW TREATMENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: TIOTROPIUM BROMIDE
Emily W Evans

To request full article click here.

OBJECTIVE: To review chronic obstructive pulmonary disease (COPD) and evaluate the role of tiotropium bromide in its treatment.

DATA SOURCES: MEDLINE was searched for articles published between 1990 and June 2004 that contained the terms tiotropium and chronic obstructive pulmonary disease.

STUDY SELECTION/DATA EXTRACTION: Selected studies documented clinical outcomes related to the use of tiotropium bromide and included a complete description of methods and results. These studies were examined to determine the extent of the effect of tiotropium on clinical outcomes involved in COPD.

DATA SYNTHESIS: Tiotropium bromide has a long duration of action and thus can be dosed just once daily. It was found to improve lung function, reduce symptoms, improve health status, and decrease exacerbations compared with both placebo and other bronchodilator medications.

CONCLUSIONS: Tiotropium appears to be a valuable addition to the current therapies available for COPD.

J Pharm Technol 2005;21:144-9.

ACPE Universal Program Number: 407-000-05-052-H01

To order the complete CE article click here.

To request full article click here.


Harvey Whitney Books


Harvey Whitney Books

 
 

the journal of Pharmacy Technology
is published by HARVEY WHITNEY BOOKS COMPANY
8044 Montgomery Road, Suite 415, Cincinnati, OH 45236-2919
P.O. Box 42696, Cincinnati, OH 45242-0696 USA
Tel. 513/793-3555, FAX 513/793-3600
Office Hours: 9-5 E.S.T.
Contact Information
All Rights Reserved. Copyright © 1998-